Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Glander

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Therapeutic Drug Monitoring|May 1, 2010
Target enzyme activity as a biomarker for immunosuppressionPetra Glander, Klemens Budde
Annals of Transplantation|September 23, 2008
Pharmacokinetic principles of immunosuppressive drugsKlemens Budde, Petra Glander
Transplant International : Official Journal of the European Society for Organ Transplantation|September 3, 2011
Accumulation of elderly ESRD patients with blood group O on the waiting listLutz Liefeldt, Klemens Budde, Petra Glander
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 6, 2011
Inosine 5'-monophosphate dehydrogenase activity as a biomarker in the field of transplantationPetra Glander, Pia Hambach, Lutz Liefeldt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 12, 2007
No evidence for a relationship between infiltrates in renal protocol biopsies and outcomeKlemens Budde, Lutz Liefeldt, Torsten Slowinski, et al.
Journal of Women'S Health (2002)|November 1, 2017
High Incidence of Ovarian Cysts in Women Receiving mTOR Inhibitors After Renal TransplantationFriederike Bachmann, Petra Glander, Klemens Budde, et al.
Archives of Toxicology|August 24, 2012
Effects of mycophenolic acid alone and in combination with its metabolite mycophenolic acid glucuronide on rat embryos in vitroFlavia Schmidt, Kathrin Eckardt, Mehdi Shakibaei, et al.
Transplantation|March 15, 2006
Reporting of rejection after renal transplantation in large immunosuppressive trials: biopsy-proven, clinical, presumed, or treated rejection?Franca Fleiner, Lutz Fritsche, Petra Glander, et al.
Expert Opinion on Drug Safety|August 28, 2010
Enteric-coated mycophenolate sodiumKlemens Budde, Michael Dürr, Lutz Liefeldt, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2010
Increased incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipientsMichael Duerr, Petra Glander, Fritz Diekmann, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Therapeutic Drug Monitoring|May 1, 2010
Target enzyme activity as a biomarker for immunosuppressionPetra Glander, Klemens Budde
Annals of Transplantation|September 23, 2008
Pharmacokinetic principles of immunosuppressive drugsKlemens Budde, Petra Glander
Transplant International : Official Journal of the European Society for Organ Transplantation|September 3, 2011
Accumulation of elderly ESRD patients with blood group O on the waiting listLutz Liefeldt, Klemens Budde, Petra Glander
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 6, 2011
Inosine 5'-monophosphate dehydrogenase activity as a biomarker in the field of transplantationPetra Glander, Pia Hambach, Lutz Liefeldt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 12, 2007
No evidence for a relationship between infiltrates in renal protocol biopsies and outcomeKlemens Budde, Lutz Liefeldt, Torsten Slowinski, et al.
Journal of Women'S Health (2002)|November 1, 2017
High Incidence of Ovarian Cysts in Women Receiving mTOR Inhibitors After Renal TransplantationFriederike Bachmann, Petra Glander, Klemens Budde, et al.
Archives of Toxicology|August 24, 2012
Effects of mycophenolic acid alone and in combination with its metabolite mycophenolic acid glucuronide on rat embryos in vitroFlavia Schmidt, Kathrin Eckardt, Mehdi Shakibaei, et al.
Transplantation|March 15, 2006
Reporting of rejection after renal transplantation in large immunosuppressive trials: biopsy-proven, clinical, presumed, or treated rejection?Franca Fleiner, Lutz Fritsche, Petra Glander, et al.
Expert Opinion on Drug Safety|August 28, 2010
Enteric-coated mycophenolate sodiumKlemens Budde, Michael Dürr, Lutz Liefeldt, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2010
Increased incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipientsMichael Duerr, Petra Glander, Fritz Diekmann, et al.
Pageof 5